查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
辐射剂量管理市场 - 全球和区域分析：按产品、方式、部署类型、应用、最终用户和国家 - 分析和预测（2025-2035 年）
市场调查报告书
商品编码
1694064

辐射剂量管理市场 - 全球和区域分析：按产品、方式、部署类型、应用、最终用户和国家 - 分析和预测（2025-2035 年）

Radiation Dose Management Market - A Global and Regional Analysis: Focus on Product, Modality, Mode of Deployment, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 | 商品交期: 1-5个工作天内

价格
简介目录

预计到 2035 年全球辐射剂量管理市场规模将以 10.45% 的复合年增长率成长。

全球辐射剂量管理市场的成长预计将受到需要诊断干预的慢性病患病率上升、对介入放射学 (IR) 的日益关注以及对患者安全和过度暴露于电离辐射的不良生物学影响的认识不断提高的推动。

辐射剂量管理市场处于新兴市场阶段。云端剂量管理解决方案的开发和对儿科手术辐射剂量管理的日益关注是全球辐射剂量管理市场的一些主要机会。此外，市场上的一些主要持续趋势包括利用减少辐射剂量的技术开发显像模式的不断增加、市场独家伙伴关係、战略商业联盟以及市场参与企业之间的各种合作关係。

预计 2024 年全球辐射剂量管理市场（按方式）将由 CT 扫描仪领域主导，并且预计这一趋势将持续到 2025-2035 年预测期年终。按产品划分，Radimetrics Enterprise Platform 占据绝对领先地位，其次是 DoseWatch。在部署类型方面，基于 Web 的部分占主导地位。从终端用户来看，医院占了绝对的份额。

放射装置数量和扫描次数的增加增加了辐射暴露的风险，从而增加了对剂量管理解决方案的需求。心血管疾病发生率的上升和导管室职业伤害的增加引发了人们对辐射暴露影响的担忧。人们对介入放射学（IR）的日益关注预计将增加对红外线成像系统的需求并增加辐射暴露的风险。人们对辐射过度暴露的担忧日益增加，导致剂量管理解决方案的采用率不断提高。预计对辐射剂量管理的认识和倡议的增强将推动剂量管理软体的采用。各国剂量优化和基准测试的进步将推动医疗机构采用剂量管理软体。

产品类型有助于了解医院和诊断中心可用的各种类型的辐射剂量控制软体。此外，您可以根据支援的模式（CT 扫描仪、X 光、CR、DR、乳房X光摄影X 光照相繫统、介入性血管造影系统/血管造影 CT、透视系统、PET 扫描仪、SPECT、混合成像）、血管造影术模式（云端基础、基于网路、本地）和可部署的最终用户（医院、诊断中心等）深入了解各种辐射剂量管理软体。

全球辐射剂量管理市场正在见证主要企业之间的伙伴关係、联盟、业务扩张和新产品的发布。伙伴关係最为普遍，占全球辐射剂量管理市场整体发展的近 70.00%。

本报告研究了全球辐射剂量管理市场，并概述了市场状况以及按产品、方式、实施类型、应用、最终用户、国家和参与市场的公司概况分類的趋势。

目录

执行摘要

第一章 市场概况

  • 概述
  • 主要趋势
  • 机会评估
  • 专利分析
  • 比较分析
  • 市场差距分析
  • 定价分析
  • 竞争格局与产品需求的变化

第二章 市场动态

  • 概述
    • 影响分析
  • 市场驱动因素
  • 市场限制
  • 市场机会

第 3 章全球辐射剂量管理市场：竞争格局

  • 概述
  • 企业策略
  • 商务策略
    • 产品发布和核准
    • 出版品
    • 许可和协议
    • 其他活动
  • 市场占有率分析

4. 全球辐射剂量管理市场（按方式），金额（百万美元），2023 年至 2035 年

  • 概述
  • CT 扫描仪
  • X 光、CR、DR
  • 乳房摄影系统
  • 介入性血管造影术系统/血管CT
  • 透视系统
  • PET 扫描器和 SPECT
  • 混合成像

5. 全球辐射剂量管理市场依产品、金额（百万美元），2023 年至 2035 年

  • 概述
  • Radimetrics 企业平台
  • DoseWatch 和 DoseWatch Explore
  • Playdose 团队
  • Nexo[达尔文]
  • 全面品质管理/剂量和剂量监测
  • 辐射剂量监测仪
  • Imalogix 平台
  • 同步剂量
  • 诺瓦多兹
  • DoseWise 门户
  • 安全CT
  • 我的 X-Raydos
  • 剂量 M
  • 剂量追踪系统
  • 道威斯卡车

6. 全球辐射剂量管理市场依实施型、金额（百万美元），2023-2035 年

  • 概述
  • 基于网路
  • 本地
  • 云端基础

7. 全球辐射剂量管理市场按应用、金额（百万美元），2023 年至 2035 年

  • 概述
  • 肿瘤学
  • 心臟病学
  • 整形外科
  • 其他的

8. 全球辐射剂量管理市场按最终用户划分，金额（百万美元），2023-2035 年

  • 概述
  • 医院
  • 诊断中心
  • 其他的

9. 全球辐射剂量管理市场按地区、金额（百万美元），2023 年至 2035 年

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 荷兰
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲和纽西兰
    • 韩国
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东
    • 中东
    • 非洲

第十章 公司简介

  • Agfa-Gevaert Group
  • Bracco
  • Bayer AG
  • Canon Inc.
  • FUJIFILM Holdings Corporation
  • Guerbet
  • General Electric Company
  • Imalogix
  • Infinitt Healthcare Co., Ltd.
  • LANDAUER
  • Medsquare
  • Medic Vision Imaging Solutions Ltd.
  • MyXrayDose Ltd.
  • Novarad Corporation
  • PACSHealth, LLC
  • Qaelum NV
  • Sectra AB
  • SST Group Inc.
  • Siemens Healthineers AG
  • Virtual Phantoms Inc.
简介目录
Product Code: BHD0692SE

Global Radiation Dose Management Market: Industry Overview

The global radiation dose management market is expected to grow at a CAGR of 10.45% by 2035. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.

Market Lifecycle Stage

The radiation dose management market is in the developing phase. The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players.

Market Segmentation:

Segmentation 1: by Modality

  • CT Scanners
  • X-Ray, CR, and DR
  • Mammography Systems
  • Interventional Angiography Systems/Angio CT
  • Fluoroscopy Systems
  • PET Scanners and SPECT
  • Hybrid Imaging

The global radiation dose management market (by modality) was dominated by the CT scanners segment in 2024, and the trend is expected to continue till the end of the forecast period 2025-2035.

Segmentation 2: by Product

  • Radimetrics Enterprise Platform
  • DoseWatch and DoseWatch Explore
  • teamplay Dose
  • NEXO [DOSE]
  • tqm/Dose and DoseMonitor
  • Radiation Dose Monitor
  • Imalogix Platform
  • Syncro-Dose
  • NovaDose
  • DoseWise Portal
  • SafeCT
  • MyXrayDose
  • DoseM
  • Dose Tracking System
  • DoseTrack

The global radiation dose management market (by product) is dominated by the Radimetrics Enterprise Platform, followed by DoseWatch.

Segmentation 3: by Mode of Deployment

  • Web-Based
  • On-Premise
  • Cloud-Based

The global radiation dose management market (by mode of deployment) is dominated by the web-based segment.

Segmentation 4: by Application

  • Oncology
  • Cardiology
  • Orthopedic
  • Other Application

The global radiation dose management market (by application) is dominated by the oncology segment.

Segmentation 5: by End User

  • Hospitals
  • Diagnostic Centers
  • Others

The global radiation dose management market (by end user) is dominated by the hospitals segment.

Segmentation 6: by Region

  • North America- U.S. and Canada
  • Europe- Germany, France, U.K., Italy, Spain, Netherlands, and Rest-of-Europe
  • Asia-Pacific- Japan, China, India, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
  • Latin America- Brazil, Mexico, and Rest-of-Latin America
  • Middle East and Africa

Recent Developments in the Global Radiation Dose Management Market

  • In December 2020, Bayer AG launched Radimetrics v3.0, the latest evolution of its enterprise dose management utility.
  • In December 2020, FUJIFILM Holdings Corporation launched the unique SYNAPSE Dose 2.0 to provide a comprehensive system for managing patient radiation exposure across several imaging modalities.
  • In January 2020, Agfa HealthCare collaborated with Maasstad Hospital in the Netherlands to support advancements in the consistency and optimization of radiation doses.
  • In April 2019, Qaelum NV signed an agreement with TOYO Corporation to distribute its dose monitoring solution, DOSE, in Japan.
  • In January 2019, SST Group, Inc. partnered with Intermountain Healthcare to implement a software platform for the Radiation Dose Monitor (RDM). The software platform permits medical professionals to manage, examine, and optimize the dose delivered to a patient during interventional procedures, medical imaging examinations, and image-guided surgery.
  • In August 2018, Imalogix launched a newer version of its radiation dose management platform with additional fluoroscopy capabilities. The software solution can automatically calculate the peak skin dose for the patient during a fluoroscopic procedure.
  • In August 2018, Guerbet LLC USA, a subsidiary of the Guerbet Group, partnered with Imalogix to decrease inconsistency and advance the quality, safety, and competence of care around radiation dose management, to enable the network health system and member facilities to monitor patient radiation dose on a per-procedure and cumulative basis.
  • In March 2018, PACSHealth, LLC launched DoseMonitor, a radiation dose management software for tracking radiation dose absorption.

Demand - Drivers and Limitations

Following are the drivers for the global radiation dose management market:

  • Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
  • The increasing prevalence of cardiovascular diseases and growing occupational hazards in cath labs lead to the growing concern surrounding the effects of radiation exposure.
  • Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.
  • Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
  • Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
  • Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.

The market is expected to face some limitations as well due to the following challenges:

  • The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
  • The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of radiation dose management software available for use in hospitals and diagnostic centers. Moreover, the study provides the reader with a detailed understanding of the different radiation dose products based on the modalities they are compatible with (CT scanners, X-Ray, CR, and DR, mammography system, interventional angiography systems/angio CT, fluoroscopy systems, PET scanners and SPECT, and hybrid imaging), the modes on which they can be deployed (cloud-based, web-based, and on-premises), and the end users who can adopt such software (hospitals, diagnostic centers, and others).

Growth/Marketing Strategy: The global radiation dose management market has seen developments by key players operating in the market, such as partnerships, collaborations and business expansions, and new product launches. Partnerships accounted for the maximum number of key developments, i.e., nearly 70.00% of the total developments in the global radiation dose management market.

Competitive Strategy: Key players in the global radiation dose management market analyzed and profiled in the study involve players that offer radiation dose software. Moreover, a detailed market share analysis of the players operating in the global radiation dose management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the key players in this market are:

  • Agfa-Gevaert Group
  • Sectra AB
  • Bracco
  • Guerbet
  • Canon Inc.
  • General Electric Company
  • FUJIFILM Holdings Corporation
  • Imalogix
  • Infinitt Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • Medic Vision Imaging Solutions Ltd.
  • Medsquare
  • MyXrayDose Ltd.
  • PACSHealth, LLC
  • Qaelum NV
  • Bayer AG
  • SST Group Inc.
  • Siemens Healthineers AG

Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

Research Methodology

1. Market Overview

  • 1.1 Overview
    • 1.1.1 Natural Radiation Sources
    • 1.1.2 Biological Effects of Radiation
    • 1.1.3 Usage of Radiation in Medical Devices
    • 1.1.4 Radiation Dose
    • 1.1.5 Effective Radiation Dose
    • 1.1.6 Factors Contributing to Unnecessary Radiation Exposure
    • 1.1.7 Radiation Exposure Trend
  • 1.2 Key Trends
  • 1.3 Opportunity Assessment
  • 1.4 Patent Analysis
  • 1.5 Comparative Analysis
  • 1.6 Market Gap Analysis
  • 1.7 Pricing Analysis
  • 1.8 Change in Competitive Landscape and Product Demand

2. Market Dynamics

  • 2.1 Overview
    • 2.1.1 Impact Analysis
  • 2.2 Market Drivers
  • 2.3 Market Restraints
  • 2.4 Market Opportunities

3. Global Radiation Dose Management Market: Competitive Landscape

  • 3.1 Overview
  • 3.2 Corporate Strategies
    • 3.2.1 Mergers and Acquisitions
    • 3.2.2 Synergistic Activities
    • 3.2.3 Business Expansions and Funding
  • 3.3 Business Strategies
    • 3.3.1 Product Launches and Approvals
    • 3.3.2 Publications
    • 3.3.3 Licenses and Agreements
    • 3.3.4 Other Activities
  • 3.4 Market Share Analysis

4. Global Radiation Dose Management Market (by Modality), Value ($million), 2023-2035

  • 4.1 Overview
  • 4.2 CT Scanners
  • 4.3 X-Ray, CR, and DR
  • 4.4 Mammography Systems
  • 4.5 Interventional Angiography Systems/Angio CT
  • 4.6 Fluoroscopy Systems
  • 4.7 PET Scanners and SPECT
  • 4.8 Hybrid Imaging

5. Global Radiation Dose Management Market (by Product), Value ($million), 2023-2035

  • 5.1 Overview
  • 5.2 Radimetrics Enterprise Platform
    • 5.2.1 Key Features
    • 5.2.2 Radimetrics Enterprise Platform- Global Market
    • 5.2.3 Installed Base
    • 5.2.4 Compatible Modalities
    • 5.2.5 Competitive Benchmarking
  • 5.3 DoseWatch and DoseWatch Explore
    • 5.3.1 Key Features
    • 5.3.2 DoseWatch and DoseWatch Explore- Global Market
    • 5.3.3 Installed Base
    • 5.3.4 Compatible Modalities
    • 5.3.5 Competitive Benchmarking
  • 5.4 teamplay Dose
    • 5.4.1 Key Features
    • 5.4.2 teamplay Dose- Global Market
    • 5.4.3 Installed Base
    • 5.4.4 Compatible Modalities
    • 5.4.5 Competitive Benchmarking
  • 5.5 NEXO [DOSE]
    • 5.5.1 Key Features
    • 5.5.2 NEXO [DOSE]- Global Market
    • 5.5.3 Installed Base
    • 5.5.4 Compatible Modalities
    • 5.5.5 Competitive Benchmarking
  • 5.6 tqm/Dose and DoseMonitor
    • 5.6.1 Key Features
    • 5.6.2 tqm/Dose and DoseMonitor- Global Market
    • 5.6.3 Installed Base
    • 5.6.4 Compatible Modalities
    • 5.6.5 Competitive Benchmarking
  • 5.7 Radiation Dose Monitor
    • 5.7.1 Key Features
    • 5.7.2 Radiation Dose Monitor- Global Market
    • 5.7.3 Installed Base
    • 5.7.4 Compatible Modalities
    • 5.7.5 Competitive Benchmarking
  • 5.8 Imalogix Platform
    • 5.8.1 Key Features
    • 5.8.2 Imalogix Platform- Global Market
    • 5.8.3 Installed Base
    • 5.8.4 Compatible Modalities
    • 5.8.5 Competitive Benchmarking
  • 5.9 Syncro-Dose
    • 5.9.1 Key Features
    • 5.9.2 Syncro-Dose- Global Market
    • 5.9.3 Installed Base
    • 5.9.4 Compatible Modalities
    • 5.9.5 Competitive Benchmarking
  • 5.10 NovaDose
    • 5.10.1 Key Features
    • 5.10.2 NovaDose- Global Market
    • 5.10.3 Installed Base
    • 5.10.4 Compatible Modalities
    • 5.10.5 Competitive Benchmarking
  • 5.11 DoseWise Portal
    • 5.11.1 Key Features
    • 5.11.2 DoseWise Portal- Global Market
    • 5.11.3 Installed Base
    • 5.11.4 Compatible Modalities
    • 5.11.5 Competitive Benchmarking
  • 5.12 SafeCT
    • 5.12.1 Key Features
    • 5.12.2 SafeCT- Global Market
    • 5.12.3 Installed Base
    • 5.12.4 Compatible Modalities
    • 5.12.5 Competitive Benchmarking
  • 5.13 MyXrayDose
    • 5.13.1 Key Features
    • 5.13.2 MyXrayDose- Global Market
    • 5.13.3 Installed Base
    • 5.13.4 Compatible Modalities
    • 5.13.5 Competitive Benchmarking
  • 5.14 DoseM
    • 5.14.1 Key Features
    • 5.14.2 DoseM- Global Market
    • 5.14.3 Installed Base
    • 5.14.4 Compatible Modalities
    • 5.14.5 Competitive Benchmarking
  • 5.15 Dose Tracking System
    • 5.15.1 Key Features
    • 5.15.2 Dose Tracking System- Global Market
    • 5.15.3 Installed Base
    • 5.15.4 Compatible Modalities
    • 5.15.5 Competitive Benchmarking
  • 5.16 DoseTrack
    • 5.16.1 Key Features
    • 5.16.2 DoseTrack- Global Market
    • 5.16.3 Installed Base
    • 5.16.4 Compatible Modalities
    • 5.16.5 Competitive Benchmarking

6. Global Radiation Dose Management Market (by Mode of Deployment), Value ($Million), 2023-2035

  • 6.1 Overview
  • 6.2 Web-Based
  • 6.3 On-Premises
  • 6.4 Cloud Based

7. Global Radiation Dose Management Market (by Application), Value ($Million), 2023-2035

  • 7.1 Overview
  • 7.2 Oncology
  • 7.3 Cardiology
  • 7.4 Orthopaedics
  • 7.5 Other Applications

8. Global Radiation Dose Management Market (by End User), Value ($Million), 2023-2035

  • 8.1 Overview
  • 8.2 Hospitals
  • 8.3 Diagnostic Centers
  • 8.4 Others

9. Global Radiation Dose Management Market (by Region), Value ($Million), 2023-2035

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 U.K
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
    • 9.3.7 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia & New Zealand
    • 9.4.5 South Korea
    • 9.4.6 Rest-of-Asia-Pacific (RoAPAC)
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest-of-Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Middle East
    • 9.6.2 Africa

10. Company Profiles

  • 10.1 Agfa-Gevaert Group
    • 10.1.1 Company Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Target Customers/ End Users
    • 10.1.4 Analyst View
  • 10.2 Bracco
    • 10.2.1 Company Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Target Customers/ End Users
    • 10.2.4 Analyst View
  • 10.3 Bayer AG
    • 10.3.1 Company Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Target Customers/ End Users
    • 10.3.4 Analyst View
  • 10.4 Canon Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Target Customers/ End Users
    • 10.4.4 Analyst View
  • 10.5 FUJIFILM Holdings Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Target Customers/ End Users
    • 10.5.4 Analyst View
  • 10.6 Guerbet
    • 10.6.1 Company Overview
    • 10.6.2 Product Portfolio
    • 10.6.3 Target Customers/ End Users
    • 10.6.4 Analyst View
  • 10.7 General Electric Company
    • 10.7.1 Company Overview
    • 10.7.2 Product Portfolio
    • 10.7.3 Target Customers/ End Users
    • 10.7.4 Analyst View
  • 10.8 Imalogix
    • 10.8.1 Company Overview
    • 10.8.2 Product Portfolio
    • 10.8.3 Target Customers/ End Users
    • 10.8.4 Analyst View
  • 10.9 Infinitt Healthcare Co., Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Product Portfolio
    • 10.9.3 Target Customers/ End Users
    • 10.9.4 Analyst View
  • 10.10 LANDAUER
    • 10.10.1 Company Overview
    • 10.10.2 Product Portfolio
    • 10.10.3 Target Customers/ End Users
    • 10.10.4 Analyst View
  • 10.11 Medsquare
    • 10.11.1 Company Overview
    • 10.11.2 Product Portfolio
    • 10.11.3 Target Customers/ End Users
    • 10.11.4 Analyst View
  • 10.12 Medic Vision Imaging Solutions Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Product Portfolio
    • 10.12.3 Target Customers/ End Users
    • 10.12.4 Analyst View
  • 10.13 MyXrayDose Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Product Portfolio
    • 10.13.3 Target Customers/ End Users
    • 10.13.4 Analyst View
  • 10.14 Novarad Corporation
    • 10.14.1 Company Overview
    • 10.14.2 Product Portfolio
    • 10.14.3 Target Customers/ End Users
    • 10.14.4 Analyst View
  • 10.15 PACSHealth, LLC
    • 10.15.1 Company Overview
    • 10.15.2 Product Portfolio
    • 10.15.3 Target Customers/ End Users
    • 10.15.4 Analyst View
  • 10.16 Qaelum NV
    • 10.16.1 Company Overview
    • 10.16.2 Product Portfolio
    • 10.16.3 Target Customers/ End Users
    • 10.16.4 Analyst View
  • 10.17 Sectra AB
    • 10.17.1 Company Overview
    • 10.17.2 Product Portfolio
    • 10.17.3 Target Customers/ End Users
    • 10.17.4 Analyst View
  • 10.18 SST Group Inc.
    • 10.18.1 Company Overview
    • 10.18.2 Product Portfolio
    • 10.18.3 Target Customers/ End Users
    • 10.18.4 Analyst View
  • 10.19 Siemens Healthineers AG
    • 10.19.1 Company Overview
    • 10.19.2 Product Portfolio
    • 10.19.3 Target Customers/ End Users
    • 10.19.4 Analyst View
  • 10.20 Virtual Phantoms Inc.
    • 10.20.1 Company Overview
    • 10.20.2 Product Portfolio
    • 10.20.3 Target Customers/ End Users
    • 10.20.4 Analyst View